Daniel Cramer

21.1k citations

23 papers · 785 indexed · h-index 14

Impact in

Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune cells in cancer
Hematology top 10%
- Hematopoietic Stem Cell Transplantation

Papers in ⓘ

Hematology 6
- Hematopoietic Stem Cell Transplantation 6
Microbiology 3

Co-authors: Jun Yan (9 shared papers)Richard Hansen (6 shared papers)Chuanlin Ding (4 shared papers)Daniel J. Allendorf (4 shared papers)José L. Marroquín (3 shared papers)Bing Li (2 shared papers)Suzanne T. Ildstad (5 shared papers)Mariusz Z. Ratajczak (3 shared papers)
Journals: Stem Cells (2 papers)The Journal of Immunology (2 papers)Journal of Clinical Oncology (2 papers)Transplantation (2 papers)Cancer Research (2 papers)
Partner nations: United States United Kingdom Poland

In The Last Decade

Daniel Cramer

23 papers receiving 755 citations

Peers

Countries citing papers authored by Daniel Cramer

Since Specialization

Citations

This map shows the geographic impact of Daniel Cramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Cramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Cramer more than expected).

Fields of papers citing papers by Daniel Cramer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Cramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Cramer. The network helps show where Daniel Cramer may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Cramer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Cramer Line = papers co-authored together Daniel Cramer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Yeast β-Glucan Amplifies Phagocyte Killing of iC3b-Opsonized Tumor Cells via Complement Receptor 3-Syk-Phosphatidylinositol 3-Kinase Pathway The Journal of Immunology ·Bing Li, Daniel J. Allendorf, Richard Hansen, José L. Marroquín, Chuanlin Ding, Daniel Cramer, Jun Yan	2006	149
2	Transient T cell depletion causes regression of melanoma metastases Journal of Translational Medicine ·Mary Ann Rasku, Amy Clem, Sucheta Telang, B. Taft, Kelly F. Gettings, Hana Gragg, Daniel Cramer, Sheron C. Lear, Kelly M. McMasters, Donald M. Miller, Jason Chesney	2008	118
3	Therapeutic potential of various β-glucan sources in conjunction with anti-tumor monoclonal antibody in cancer therapy Cancer Biology & Therapy ·Michael F Driscoll, Richard Hansen, Chuanlin Ding, Daniel Cramer, Jun Yan	2009	59
4	Yeast glucan particles activate murine resident macrophages to secrete proinflammatory cytokines via MyD88- and Syk kinase-dependent pathways Clinical Immunology ·Bing Li, Daniel Cramer, Stephanie A. Wagner, Richard Hansen, Chelsea King, Shelly Kakar, Chuanlin Ding, Jun Yan	2007	58
5	A Novel Role of Complement in Mobilization: Immunodeficient Mice Are Poor Granulocyte-Colony Stimulating Factor Mobilizers Because They Lack Complement-Activating Immunoglobulins Stem Cells ·Ryan Reca, Daniel Cramer, Jun Yan, Mary J. Laughlin, Anna Janowska‐Wieczorek, Janina Ratajczak, Mariusz Z. Ratajczak	2007	54
6	β-Glucan enhances complement-mediated hematopoietic recovery after bone marrow injury Blood ·Daniel Cramer, Daniel J. Allendorf, Jarosław Baran, Richard Hansen, José L. Marroquín, Bing Li, Janina Ratajczak, Mariusz Z. Ratajczak, Jun Yan	2005	45
7	Discovery of a Broad-Spectrum Antiviral Compound That Inhibits Pyrimidine Biosynthesis and Establishes a Type 1 Interferon-Independent Antiviral State Antimicrobial Agents and Chemotherapy ·Dong-Hoon Chung, Jennifer E. Golden, Robert S. Adcock, Chad E. Schroeder, Yong‐Kyu Chu, Julie Sotsky, Daniel Cramer, Paula M. Chilton, Chisu Song, Manu Anantpadma, Robert A. Davey, Aminul Islam Prodhan, Xinmin Yin, Xiang Zhang	2016	44
8	Yeast-Derived β-Glucan Augments the Therapeutic Efficacy Mediated by Anti–Vascular Endothelial Growth Factor Monoclonal Antibody in Human Carcinoma Xenograft Models Clinical Cancer Research ·Carolina Salvador, Bing Li, Richard Hansen, Daniel Cramer, Maiying Kong, Jun Yan	2008	41
9	Combined Yeast β-Glucan and Antitumor Monoclonal Antibody Therapy Requires C5a-Mediated Neutrophil Chemotaxis via Regulation of Decay-Accelerating Factor CD55 Cancer Research ·Bing Li, Daniel J. Allendorf, Richard Hansen, José L. Marroquín, Daniel Cramer, Claire L. Harris, Jun Yan	2007	40
10	Graft facilitating cells are derived from hematopoietic stem cells and functionally require CD3, but are distinct from T lymphocytes Experimental Hematology ·H. Leighton Grimes, Carrie L. Schanie, Yiming Huang, Daniel Cramer, Francine Rezzoug, Isabelle Fugier‐Vivier, Suzanne T. Ildstad	2004	33
11	THE ROLE OF ????- AND ????-T CELLS IN ALLOGENEIC DONOR MARROW ON ENGRAFTMENT, CHIMERISM, AND GRAFT-VERSUS-HOST DISEASE1 Transplantation ·Yiming Huang, Daniel Cramer, Mukunda B. Ray, Paula M. Chilton, Xingyi Que, Suzanne T. Ildstad	2001	27
12	Matching at the MHC class I K locus is essential for long-term engraftment of purified hematopoietic stem cells: a role for host NK cells in regulating HSC engraftment Blood ·Yiming Huang, Francine Rezzoug, Paula M. Chilton, H. Leighton Grimes, Daniel Cramer, Suzanne T. Ildstad	2004	26
13	Mobilization of Hematopoietic Progenitor Cells by Yeast-Derivedβ-Glucan Requires Activation of Matrix Metalloproteinase-9 Stem Cells ·Daniel Cramer, Stephanie A. Wagner, Bing Li, Jingjing Liu, Richard Hansen, Ryan Reca, Wan Wu, Ewa Zuba Surma, Damian A. Laber, Mariusz Z. Ratajczak, Jun Yan	2008	26
14	CD8+, αβ-TCR+, and γδ-TCR+ Cells in the Recipient Hematopoietic Environment Mediate Resistance to Engraftment of Allogeneic Donor Bone Marrow The Journal of Immunology ·Hong Xu, Beate G. Exner, Daniel Cramer, Michael K. Tanner, Yvonne M. Mueller, Suzanne T. Ildstad	2002	23
15	Giant Basal Cell Carcinomas Express Neuroactive Mediators and Show a High Growth Rate: A Case–Control Study and Meta-Analysis of Etiopathogenic and Prognostic Factors American Journal of Dermatopathology ·Mohammad‐Ali Yazdani Abyaneh, Peter A. Engel, Andrzej Słomiński, Bruce D. Ragsdale, Richard L. Agag, Daniel Cramer, J. Andrew Carlson	2016	12
16	Development and evaluation of murine lung-specific disease models for Pseudomonas aeruginosa applicable to therapeutic testing Pathogens and Disease ·Matthew B. Lawrenz, Ashley E. Biller, Daniel Cramer, Jennifer Kraenzle, Julie Sotsky, Carol D. Vanover, Deborah R. Yoder-Himes, Angela Pollard, Jonathan M. Warawa	2015	11
17	Hematopoietic stem cells from the marrow of mice treated with flt3 ligand are significantly expanded but exhibit reduced engraftment potential1 Transplantation ·Yvonne M. Mueller, Daniel Cramer, Yiming Huang, Beate G. Exner, Suzanne T. Ildstad	2002	7
18	Validated Preclinical Mouse Model for Therapeutic Testing against Multidrug-Resistant Pseudomonas aeruginosa Strains Microbiology Spectrum ·Jonathan M. Warawa, Xiaoxian Duan, Charles D. Anderson, Julie Sotsky, Daniel Cramer, Tia L. Pfeffer, Haixun Guo, Scott Adcock, Alexander J. Lepak, David R. Andes, Stacey Slone, Arnold J. Stromberg, Jon D. Gabbard, William E. Severson, Matthew B. Lawrenz	2022	5
19	Yeast beta-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via CR3-Syk-PI3-kinase pathway. Cancer Research ·Jun Yan, Bing Li, Daniel J. Allendorf, Richard Hansen, Daniel Cramer, Chuanlin Ding	2006	2
20	Transient T-cell depletion causes regression of melanoma metastases Journal of Clinical Oncology ·Jason Chesney, Mary Ann Rasku, Amy Clem, S. Telang, B. Taft, Kelly F. Gettings, Hana Gragg, Daniel Cramer, Sheron C. Lear, K. M. McMasters, D. M. Miller	2008	2

About Daniel Cramer

Daniel Cramer is a scholar working on Hematology, Microbiology, Immunology, Molecular Medicine and Oncology, having authored 23 papers that have together received 785 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (6 papers), Polysaccharides and Plant Cell Walls (6 papers), T-cell and B-cell Immunology (5 papers), Immune Cell Function and Interaction (4 papers), Fungal Biology and Applications (4 papers), Cancer Treatment and Pharmacology (3 papers), CAR-T cell therapy research (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Immunology (363 citations), Hematology (127 citations), Transplantation (20 citations), Biotechnology (55 citations) and Oncology (160 citations). Daniel Cramer has collaborated with scholars based in United States, United Kingdom and Poland. Frequent co-authors include Jun Yan, Richard Hansen, Chuanlin Ding, Daniel J. Allendorf, José L. Marroquín, Bing Li, Suzanne T. Ildstad, Mariusz Z. Ratajczak, Yiming Huang and Bing Li. Their work appears in journals such as Stem Cells, The Journal of Immunology, Journal of Clinical Oncology, Transplantation and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact